Silexion Therapeutics Corp (SLXN)
NGM · Common · CUSIP G1281K106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for SLXN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
G1281K106
Business: Silexion Therapeutics Corp is a clinical stage, oncology-focused biotechnology company dedicated to the development of innovative treatments for unsatisfactorily treated solid tumor cancers which have the mutated KRAS oncogene.

Company Contact

CEO
Ilan Hadar
CFO
Mirit Horenshtein Hadar
Investor Relations
Chuck Padala,LifeSci Advisors · Chuck@lifesciadvisors.com
General Email
mirit@silexion.com
SEC EDGAR Filings
View filings »